Applied BioCode at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Applied BioCode brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 936. Its session covers a multiplex panel for sexually transmitted infections and antimicrobial resistance markers, including how such panels get reimbursed. The company makes multiplex molecular panels for gastrointestinal, respiratory and other pathogens.

OrganizationAMP 2026 Attendance
Applied BioCode
Santa Fe Springs, CA
Diagnostics
Multiplex molecular diagnostic panels detecting gastrointestinal, respiratory and other pathogens, plus autoimmune, allergy, gut microbiome and veterinary assays.
Booth
Exhibiting at Booth 936
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
2:00pm–3:50pm
Evaluation of the BioCode® STI + Resistance Panel for STI Detection, Antimicrobial Resistance Markers, and Multiplex STI Panels Reimbursement Considerations
Performance of a multiplex panel detecting chlamydia, gonorrhea, mycoplasma and trichomonas with resistance markers, plus reimbursement.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Applied BioCode

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction